Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - TransBiotec Inc.

v3.7.0.1
Stockholders' Equity - TransBiotec Inc. - USD ($)
Common Stock [Member]
Additional Paid-In Capital
Accumulated Deficit
Stockholders' Equity - TransBiotec Inc.
Total
Noncontrolling Interest
Beginning Balance, Shares at Dec. 31, 2014 58,416,660          
Biginning Balance, Amount at Dec. 31, 2014 $ 585 $ 12,716,630 $ (15,777,222) $ (3,060,007) $ (3,094,794) $ (34,787)
Stock issued for cash, Shares 834,408          
Stock issued for cash, Amount $ 7 1,495 1,502 1,502
Stock issued for services, Shares 1,000,000          
Stock issued for services, Amount $ 10 3,890 3,900 3,900
Paid in capital - beneficial conversion feature 25,000 25,000 25,000
Paid in capital - stock option expense 26,229 26,229 26,229
Paid in capital - Gain on related party debt conversion 1,472,384 1,472,384 1,472,384
Share exchange - noncontrolling interest   (5,012) (5,012)
Paid in capital - Gain on related party forgiveness of debt 108,000 108,000 108,000
Net Loss (691,734) (691,734) (691,734)
Ending Balance, Shares at Dec. 31, 2015 60,251,068          
Ending Balance, Amount at Dec. 31, 2015 $ 602 14,353,628 (16,468,956) (2,114,726) (2,154,525) (39,799)
Stock issued for cash, Shares 5,000,000          
Stock issued for cash, Amount $ 50 24,950 25,000 25,000
Stock conversion of note payable , Shares 2,500,000          
Stock conversion of note payable, Amount $ 25 9,725 9,750 9,750
Paid in capital - beneficial conversion feature (21,500) (21,500) (21,500)
Paid in capital - stock option expense (7,512) (7,512) (7,512)
Paid in capital - Gain on related party debt conversion (83,823) (83,823) (83,823)
Share exchange - noncontrolling interest   (4,102) (4,102)
Paid in capital - Reclassification of common share equivalents to derivative liabilities   (180,038) (180,038) (180,038)
Net Loss (595,130) (595,130) (595,130) (595,130)
Ending Balance, Shares at Dec. 31, 2016 67,751,068          
Ending Balance, Amount at Dec. 31, 2016 $ 677 $ 14,095,430 $ (17,064,086) $ (2,967,979) $ (3,011,880) $ (43,901)